Leptospirosis caused by leptospiral infection can result in multiple-organ failure, including acute kidney injury (7) . Although tubulointerstitial nephritis is the most common histological finding in patients with leptospirosis, tubulointerstitial fibrosis eventually develops if chronic leptospiral infection is left untreated. While leptospirosis is well established as a cause of tubulointerstitial fibrosis in dogs and rats, leading to chronic renal failure (28, 30) , it is also apparent that chronic leptospiral infection may result in renal disease in humans (21) . Persistent infection may cause interstitial nephritis and fibrosis in human biopsy samples (21) , and more recent studies have demonstrated that this may lead to end-stage renal failure (2) . Leptospira santorosai serovar Shermani (referred to hereafter as serovar Shermani) is the main pathogenic leptospira causing renal failure in Taiwan (4) . We have recently demonstrated that stimulation of proximal tubular cells with serovar Shermani detergent extract stimulated the accumulation of extracellular matrix (ECM) proteins such as type I and type IV collagens, supporting the notion that leptospirosis can cause tubulointerstitial fibrosis (32) .
Toll-like receptors (TLRs) that recognize pathogen-associated molecular patterns are essential for the innate immune response and play a fundamental role in antimicrobial responses against viruses and bacteria (1). For example, TLR2 and TLR4 have been implicated in cellular responses to lipopolysaccharide (LPS), and bacterial lipoproteins, the major constituents of the Gram-negative bacterial outer membrane (40) . Binding of specific ligands to TLR2 leads to recruitment of an intracellular adaptor protein, myeloid differentiation factor 88 (MyD88), which subsequently activates tumor necrosis factor receptor-associated factor 6 (TRAF6) by phosphorylating interleukin-1 receptor-associated kinase 4 (IRAK-4) and IRAK-1 (16) . Finally, the nuclear factor-B (NF-B) and mitogen-activated protein kinase pathways are activated, thus leading to induced inflammatory gene expression. It has been shown that TLR4 enhances hepatic fibrogenesis (27) . However, little is known about whether TLRs are implicated in the development of renal fibrosis.
We previously demonstrated that serovar Shermani detergent extract induces an increase in inflammatory cytokines and chemokines through the TLR2-mediated but not the TLR4-mediated pathway (36) . It also stimulates ECM accumulation through transforming growth factor ␤ (TGF-␤)/Smad3-dependent signaling pathway (32) . Werts et al. also demonstrate that L. interrogans outer membrane LPS and lipoproteins activate macrophages through TLR2 in human cells (34) . Nevertheless, it remains unclear whether TLRs play a role in serovar Shermani detergent extract-induced alteration of ECM molecules. We show here that serovar Shermani detergent extract increases fibronectin production via the TLR2-mediated pathway, providing the first evidence that the TLR-associated signaling pathways play an important role in ECM accumulation and implying a possible association between innate immunity and renal fibrosis.
MATERIALS AND METHODS

Materials.
Curcumin was purchased from Sigma-Aldrich (St. Louis, MO) and 6-amino-4-(4-phenoxyphenylethylamino)quinazoline (QNZ) was obtained from Calbiochem (La Jolla, CA). Pam(3)CsK(4) was obtained from InvivoGen (San Diego, CA). Anti-fibronectin antibody was purchased from Abcam (Cambridge, United Kingdom).
Cell culture. Immortalized human renal proximal tubular cells, HK-2, were cultured in Dulbecco modified Eagle medium/Ham F-12 (Life Technologies, Paisley, United Kingdom) supplemented with 5% fetal calf serum (Biological Industries, Ltd., Cumbernauld, United Kingdom), 2 mM glutamine (Life Technologies, Ltd., Paisley, United Kingdom), 20 mM HEPES buffer (Gibco-BRL, Paisley, United Kingdom), 0.4 g of hydrocortisone/ml, 5 g of insulin/ml, 5 g of transferrin/ml, and 5 ng of sodium selenite/ml (Sigma Chemical Company, Ltd., Poole, United Kingdom).
To minimize the effect of serum-promoted cell proliferation and serum-mediated alteration of cell function and to avoid interference of serum-contained fibronectin in fibronectin quantification, all experiments were performed under serum-free conditions.
Live serovar Shermani was purchased from the American Type Culture Collection (ATCC; Manassas, VA). Leptospires were cultured in medium containing 10% Leptospira enrichment Elinghausen-McCullough-Johnson-Harris (EMJH) medium and 90% Leptospira medium base EMJM medium (Difco, Sparks, MD) at 28°C for 5 to 7 days (14, 38) . Prior to addition to the cells, the number of leptospires was determined by direct counting in a counting chamber under dark-field microscopy (18, 25) .
Preparation of serovar Shermani detergent extract. The extraction method to obtain L. santorosai serovar Shermani detergent extract has been described previously (37) . Briefly, serovar Shermani (ATCC 43286) was grown in 10% EMJH leptospiral enrichment medium (Difco). Culture medium (500 ml) containing 10 8 leptospires/ml enumerated by using dark field-microscopy was collected (18) . The serovar Shermani detergent extract was extracted with 1% Triton X-114, 10 mM Tris (pH 8), and 1 mM EDTA. After centrifugation, the hydrophobic fraction was collected, and 2% Triton X-114 was used for further phase partitioning. After centrifugation for 10 min at 2,000 ϫ g, the aqueous phases were removed, and the hydrophobic detergent fraction was precipitated with acetone. The precipitant was then dissolved in water, resulting in a serovar Shermani detergent extract yield of 250 g.
Gene silencing by siRNA. To knock down MyD88 and TRAF6 expression, RNA interference was used to inhibit functions of MyD88 and TRAF6 mRNAs. On-Target plus SMARTpool short interfering RNA (siRNA) of MyD88 and TRAF6 was purchased from Dharmacon, Inc. (Lafayette, CO).
Briefly, 0.5 to 1.5 g of siRNA against MyD88 or TRAF6 or control siRNA was diluted in serum-free medium to give a final volume of 100 l. Subsequently, RNAiFectI transfection reagent was mixed with diluted siRNA at a ratio from 6:1 to 3:1. After incubation for 15 min at room temperature, the mixture was added to the culture medium. After transfection for 24 h, cells were incubated in the presence or absence of Leptospira santarosai serovar Shermani OMP under serum-free condition for 24 or 48 h. Cells were then lysed and subjected to real-time PCR or Western blot analysis.
Real-time PCR. The real-time PCR method has been previously described (31) . Briefly, total RNA was isolated from the cells and reverse transcribed to DNA. Real-time PCR was performed according to the manufacturer's instructions using an ABI Prism 7700 with SYBR green I as a double-stranded DNAspecific dye (PE-Applied Biosystems, Cheshire, Great Britain). The primers used to assay fibronectin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript levels (fibronectin, 5-GTGTGACCCTCATGAGGCAAC-3 and 5-CT GGCCTCCAAAGCATGTG-3; GAPDH, 5-TTCCAGGAGCGAGATCCCT-3 and 3-CACCCATGACGAACATGGG-5) were constructed to be compatible with a single reverse transcription-PCR thermal profile (95°C for 10 min, 40 cycles at 95°C for 30 s, and 60°C for 1 min) (13) . The accumulation of the PCR product was monitored in real time (PE-Applied Biosystems). Experimental results are presented as the transcript levels of the analyzed genes relative to GAPDH transcript level.
Western blot analysis. Total cellular protein extraction was performed as described previously (31) . Equal amount of proteins were mixed with an equal volume of reducing sodium dodecyl sulfate (SDS) sample buffer and boiled for 5 min at 95°C. Protein samples were resolved using SDS-10% polyacrylamide gel electrophoresis (PAGE) and then electroblotted on nitrocellulose membranes (Millipore, Billerica, MA). After electroblotting, nonspecific binding was blocked with a 5% nonfat milk solution. The membrane was then incubated with primary antibodies overnight at 4°C, followed by incubation with a horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. The proteins were visualized by using enhanced chemiluminescence (Amersham Biosciences, Amersham, United Kingdom). The same blot was reprobed with anti-tubulin antibody (NeoMarkers, Fremont, CA) to examine tubulin expression as a control.
Electrophoretic mobility shift assay (EMSA). Nuclear proteins were prepared according to the method of Satriano and Schlondorff (24) . Briefly, cells were harvested with trypsin and collected by centrifugation. Cell pellets were washed with ice-cold phosphate-buffered saline (PBS) and suspended with buffer A containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 3.5 mM dithiothreitol (DTT), and protease inhibitor (Complete; Boehringer Mannheim). Cell suspensions were incubated on ice for 10 min and centrifuged for 5 min at 650 ϫ g. The pellets were resuspended in the same buffer A containing 0.5% Nonidet P-40 on ice for 15 min and mixed by pipetting vigorously for lysis. The nuclear fractions were pelleted for 5 min at 6,000 ϫ g and resuspended in buffer B containing 5 mM HEPES (pH 7.9), 26% glycerol, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 0.4 M NaCl. After incubation on ice for 30 min and centrifugation for 10 min at 12,000 ϫ g, the supernatants containing nuclear protein were subsequently used.
Whole-cell nuclear extracts were subjected to assays for NF-B-binding activity using NF-B consensus oligonucleotide (59-AGTTGAGGGGACTTTAGG C-39; Promega, Madison, WI) radiolabeled with [␥- After incubation at room temperature for 20 min, the protein-DNA complexes were resolved on native 4% polyacrylamide gel in a Tris-borate-EDTA buffer system and run at 200 V for 1.5 h in a 4°C cold room. Gels were transferred to Whatman paper, dried, and exposed to Kodak XR5 film (Rochester, NY) in film holders for 4 to 16 h at 280°C.
Immunohistochemistry. With the permission of the Ethics Committee of our hospital, residual renal biopsy specimens in our tissue bank obtained from five leptospirosis patients between January 2000 and December 2003 were analyzed for the deposition of fibronectin and type I collagen. Normal tissues away from the edge of renal cell carcinoma (RCC) obtained from five RCC patients undergoing nephrectomy were used as negative controls. The average time from the onset of leptospiral infection to the day of renal biopsy was 37 Ϯ 22 days.
Kidney specimens were fixed with 4% paraformaldehyde and embedded in paraffin. After deparaffinization, sections were treated with 10 mM sodium citrate and heated in a microwave for 10 min to expose antigenicities. Sections were then immersed in 3% H 2 O 2 in methanol and blocked with 5% bovine albumin-PBS for 20 min. After incubation with rabbit anti-fibronectin or goat anti-type I collagen for 1 h, the sections were treated with relevant biotin-conjugated antibodies, and the fibronectin or type I collagen immunostaining was then displayed by using a Vectastain ABC kit (Vector Laboratories, Burlingame, CA).
To quantify fibronectin immunostaining, the integrated image intensity in eight consecutively selected nonoverlapping and area-fixed fields of renal cortex and medulla at ϫ400 magnification in each kidney specimen was calculated by using MetaMorph imaging software (Molecular Devices Co., Sunnyvale, CA) (33) .
Statistical analysis. All data are presented as means Ϯ the standard error of the mean. Statistical analysis was performed by using analysis of variance with Tukey's post hoc test. A P value of Ͻ0.05 was considered statistically significant.
RESULTS
L. santorosai serovar Shermani detergent extract induced an increase in fibronectin gene expression and protein production. To assess whether the pathogenic leptospira, serovar Shermani increased fibronectin, we first assessed fibronectin production after the addition of serovar Shermani detergent extract to renal proximal tubular cells (HK-2 cells). After the addition of 0.005 to 0.2 g of serovar Shermani detergent extract/ml for 48 h, both real-time PCR and Western blot analysis demonstrated a dose-dependent increase in fibronec- tin gene expression and protein, respectively ( Fig. 1A and C) . Maximal increase in fibronectin gene expression and protein production was seen after the addition of 0.1 g of serovar Shermani detergent extract/ml. Similarly, addition of serovar Shermani detergent extract led to a time-dependent increase of fibronectin gene expression ( Fig. 1B and D) . Fibronectin gene expression and protein production reached maximal response after a 48-h stimulation. Lipoproteins are the most abundant components in the leptospiral total protein profile (5, 10, 42) . To assess whether the protein components are important for stimulation of fibronectin production, serovar Shermani detergent extract was inactivated by boiling for 30 min or treatment with proteinase K (100 to 200 M) at 37°C for 30 min. The result of Western blot analysis demonstrated that the heat-or proteinase-pretreated serovar Shermani detergent extract-stimulated fibronectin induction was reduced compared to untreated leptospiral detergent extract (Fig. 1E) . This result suggests that the protein components in serovar Shermani detergent extract may be required to promote fibronectin production.
To determine whether fibronectin deposition is increased in patients with leptospirosis, fibronectin immunostaining in kidney specimens obtained from five patients with leptospiral infection was assessed by immunohistochemistry. Renal histology using hematoxylin and eosin (H&E) stain in leptospirosis patients demonstrated prominent tubulointerstitial fibrosis (Fig. 2B) . Immunohistochemistry results showed that the fibronectin immunostaining intensity was markedly increased in the kidneys of patients with leptospiral infection (Fig. 2D ) compared to that in normal kidney tissues (Fig. 2C) . Similarly, type I collagen immunostaining intensity was also increased in leptospirosis patients (data not shown). Immunostaining intensity quantification results confirmed a significant increase in fibronectin deposition in the kidneys of patients with leptospirosis (Fig. 2G) .
The serovar Shermani detergent extract-induced increase in fibronectin production was mediated through TLR2. To define the role of TLR2 and TLR4 in serovar Shermani detergent extract-induced increase in fibronectin production, TLR2 and TLR4 gene expressions were manipulated by gene silencing using siRNA (12) . Reduced TLR2 and TLR4 gene expression was confirmed by real-time PCR (Fig. 3A and B) . Both realtime PCR and Western blot analysis showed that the suppres- Normal tissues cut from residual kidney specimens obtained from five nephrectomized patients with renal cell carcinoma were used as the control and stained for H&E staining (A) or fibronectin immunostaining (C). (E and F) A negative control from normal tissues (E) and diseased tissues (F) for fibronectin immunostaining was performed using only the secondary antibody with omission of the primary antibody (anti-fibronectin). (G) The integrated image intensity of fibronectin in eight consecutively selected nonoverlapping and area-fixed fields at a ϫ400 magnification in each kidney specimen was calculated as described in Materials and Methods. The results are presented as the relative fold immunostaining intensity over that of the control Ϯ the SE ( * , P Ͻ 0.05, leptospirosis patients versus control patients).
VOL. 79, 2011 LEPTOSPIROSIS-INDUCED FIBRONECTIN PRODUCTION VIA TLR2 1137
sion of TLR2 expression reduced the serovar Shermani detergent extract-induced increase in fibronectin production ( Fig.  3C and D) . In contrast, inhibition of TLR4 expression did not affect this reaction. The serovar Shermani detergent extract-induced increase in fibronectin production was mediated through the TLR2-associated signaling pathway. MyD88 and TRAF6 are important downstream mediators of the TLR2-associated signaling pathway (16) . To assess whether MyD88 and TRAF6 are implicated in the serovar Shermani detergent extract-induced increase in fibronectin production, MyD88 and TRAF6 gene expressions were knocked down by siRNA. The results of realtime PCR and Western blot analysis demonstrated that inhibition of MyD88 gene expression by MyD88 siRNA reduced the serovar Shermani detergent extract-induced increase in fibronectin expression and protein production ( Fig. 4A and B) . In contrast, treatment with control siRNA did not affect this response. Similarly, inhibition of TRAF6 expression by gene silencing led to a reduction in the serovar Shermani detergent extract-induced increase in fibronectin expression (Fig. 4C ) and protein production (Fig. 4D) .
The serovar Shermani detergent extract-mediated increase in fibronectin production required NF-B activation. It has been shown that signal transduction of the TLR2-dependent signaling pathway propagates through transcription factors, including NF-B, to regulate the production of cytokines and chemokines (15) . The effect of serovar Shermani detergent extract on NF-B activation was determined by EMSA to assess the amount of NF-B binding to its consensus oligonucleotide. The results of EMSA demonstrated that addition of serovar Shermani detergent extract led to an increase in NF-B transcription factor binding to its specific oligonucleotide (Fig. 5A) . Enhancement of NF-B binding to its oligonucleotide by serovar Shermani detergent extract was abrogated by gene silencing of TLR2 but not TLR4.
To further determine whether NF-B was implicated in serovar Shermani detergent extract-induced increase in fibronectin production, an NF-B inhibitor, curcumin, was used to block NF-B activation prior to the administration of serovar Shermani detergent extract. The results of Western blot analysis revealed that curcumin abrogated serovar Shermani detergent extract-induced increase in fibronectin production in a dose-dependent manner, suggesting an important role for NF-B in this reaction (Fig. 5B) . Similarly, another NF-B activation inhibitor, QNZ, also inhibited serovar Shermani detergent extract-induced increase in fibronectin production (Fig. 5C) .
A specific TLR2 agonist mimicked the effect of serovar Shermani detergent extract on stimulation of fibronectin production. Since serovar Shermani detergent extract-induced increase in fibronectin production in HK-2 cells was mediated through TLR2, we examined whether a specific TLR2 agonist, Pam(3)CSK(4), could also stimulate increased fibronectin production. After 48-h administration of Pam(3)CsK(4) to HK-2 cells, Western blot analysis demonstrated a dose-dependent increase in fibronectin production (Fig. 6A) . Specificity of the TLR2 agonist-mediated increase in fibronectin production was confirmed since inhibition of TLR2 but not TLR4 expression blocked Pam(3)CsK(4)-stimulated fibronectin production (Fig. 6B) . Furthermore, inhibition of MyD88 gene expression (Fig. 6C) .
Live serovar Shermani induced increased fibronectin production mainly through TLR2 and MyD88. To assess whether live leptospires can also induce fibronectin production, live serovar Shermani was added to HK-2 cells. After 2-day administration of live serovar Shermani at different loads, the results of Western blot analysis showed increased fibronectin production in a dose-dependent manner (Fig. 7A) . Since the major component of serovar Shermani detergent extract in triggering fibronectin production is TLR2 and MyD88 dependent (see above), we determined whether TLR2 and MyD88 are also required in live serovar Shermani-induced fibronectin production. After 24-h administration of TLR2 and MyD88 siRNA, live leptospires were added to cells for further 2 days. The results showed that knockdown of either TLR2 or MyD88 gene expression abrogated live serovar Shermani-induced fibronectin production ( Fig. 7B and C) . In contrast, inhibition of TLR4 gene expression by siRNA did not block this response.
DISCUSSION
The kidney is the main target of acute or chronic leptospiral infection (35) . In humans, leptospiral infection has been shown to cause tubulointerstitial fibrosis, leading to chronic renal insufficiency and end-stage renal disease requiring hemodialysis (2, 4) . Although it has been well documented that tubulointerstitial fibrosis is an important consequence of leptospiral infection in animal studies, the mechanism underlying this is poorly defined. We previously showed that human renal proximal tubular cells produce ECM proteins, including type I and type IV collagens, in response to serovar Shermani detergent extract stimulation (32) . In the present study, we also demonstrated that the addition of serovar Shermani detergent extract to human renal proximal tubular cells led to an increase in another ECM protein, fibronectin.
Although many profibrotic factors such as TGF-␤1 have been observed to promote tissue fibrosis, innate immunity has recently also been shown to play a crucial role in the development and progression of tissue fibrosis (27) . For example, TLR4 has been implicated in hepatic fibrogenesis since TLR4 mutant mice develop less severe liver fibrosis after bile duct ligation or thioacetamide injection compared to TLR4 wildtype mice, indicating a requirement for TLR4 in the development of liver fibrosis. In cases of pulmonary fibrosis, a consequence of lung injury, Yang et al. have the demonstrated that knockout or blockade of TLR2 expression by a TLR2-neutralizing antibody attenuates the progression of pulmonary fibrosis induced by bleomycin, a TLR2 agonist (39) . In the present study, a serovar Shermani detergent extract-induced increase in fibronectin was alleviated when TLR2 was knocked down by TLR2 gene silencing. In contrast, TLR4 knockdown did not alter the effect of serovar Shermani detergent extract on fibronectin production. Furthermore, a specific TLR2 agonist also induced an increase in fibronectin production, confirming an association between the activation of innate immunity and matrix deposition. We have previously demonstrated that serovar Shermani detergent extract induces increased inflammatory chemokines such as nitric oxide (iNOS) and MCP-1 through TLR2 and not TLR4 in mouse proximal tubular cells. The present study also identified a crucial role of TLR2 in pathogenesis of leptospirosis-associated matrix deposition. Although it is well documented that tubulointerstitial inflammation is closely associated with renal fibrosis (22) , the molecular link remains elusive. The present study suggests that innate immunity may play a direct role in the initiation of both processes. Both MyD88 and TRAF6 are fundamental mediators of the TLR-propagated cascade (17) . MyD88 is an important adaptor molecule that interacts directly with the TLRs on the cell plasma membrane (19) . In the present study, we demonstrate that the serovar Shermani detergent extract-induced increase in fibronectin production was attenuated by silencing MyD88 gene expression. It has been reported that bleomycin-induced pulmonary fibrosis is significantly reduced in MyD88-deficient mice (8) . Furthermore, blockade of MyD88 by transfection of rats with dominant-negative MyD88 results in a significant reduction of cardiac hypertrophy and fibrosis in aortic banding-induced pressure overload cardiac fibrosis (9) . Similarly, the present study also displayed that inhibition of TRAF6 by gene silencing reduced serovar Shermani detergent extractinduced increase in fibronectin production. Our study therefore suggests that both MyD88 and its downstream adaptor, TRAF6, lie downstream of the serovar Shermani detergent extract-induced activation of TLR and mediate subsequent matrix deposition.
NF-B is a crucial transcription factor in the TLR-mediated signaling pathways (41) . Upon activation of TLR2 and its downstream mediators MyD88 and TRAF6, cytoplasmic NF-B is eventually translocated into the nucleus to trigger targeted gene expression. We have previously shown that serovar Shermani detergent extract can activate NF-B, which causes an increase in inflammatory cytokines (37) . The present study demonstrated that serovar Shermani detergent extract activated NF-B and that inhibition of NF-B by curcumin abrogated the serovar Shermani detergent extract-induced increase in fibronectin production. An implied role of NF-B activation in liver fibrosis has been documented (6). Chen et al. showed that inhibition of NF-B by its inhibitor curcumin blocks LPS-induced increased connective tissue growth factor and type I collagen in cultured hepatic stellate cells, suggesting that NF-B is a critical participant in hepatic fibrosis (3) . Our data are consistent with the work on hepatic fibrosis.
Lipoproteins are the most abundant components of the leptospiral total protein profile (5, 10, 42) . Over the past few decades, several leptospiral lipoproteins have been shown to be responsible for a leptospirosis-mediated immune response (26) . In the present study, serovar Shermani detergent extract after inactivation by pretreatment with heat or proteinase failed to stimulate fibronectin production, suggesting that the protein components in serovar Shermani detergent extracts may play a role in promoting fibronectin production. Interestingly, Roh et al. have demonstrated that different forms of low-density lipoprotein enhance the synthesis of ECM proteins, including fibronectin (23) . Whether these findings and our results share molecular mimicry requires further investigation. Nevertheless, the outer membrane extraction method used in the present study may concomitantly harvest protein components and LPS from pathogenic leptospira (11) . In fact, the activity of serovar Shermani detergent extract in the stimulation of fibronectin production was partially but not completely abolished by pretreatment with proteinase (Fig. 1E) . Since leptospiral LPS is also recognized by TLR2 (20) , the activity of serovar Shermani detergent extract could partly be mediated by LPS contained in the extracts. It is a limitation of the present study that we cannot determine the contribution of leptospiral LPS to serovar Shermani detergent extract-induced fibronectin production.
In the present study, live serovar Shermani also induced fibronectin production that was abrogated by inhibition of TLR2 and MyD88 expression. In line with the finding that serovar Shermani detergent extract-induced fibronectin production requires TLR2 and MyD88 functionalities, live leptospire-induced fibronectin deposition also depends on TLR2 and MyD88. It was recently shown that fibronectin proteolytic fragments can upregulate TLR2 expression in human articular chondrocytes (29) . In the present study, serovar Shermani detergent extract promoted fibronectin production through TLR2. It requires further elucidation whether the increase in fibronectin production stimulated by serovar Shermani detergent extract can subsequently enhance TLR2 upregulation, thus causing a positive-feedback loop that amplifies leptospirosis-induced fibrosis.
In conclusion, we showed here that serovar Shermani detergent extract can induce fibronectin production through the TLR2-associated cascades, including its downstream adaptors, MyD88 and TRAF6, and the transcription factor NF-B, providing evidence of an association between TLRs and leptospirosis-mediated ECM deposition and implying an association between innate immunity and renal fibrosis. 
